Wearable Sensors for Quantitative Assessment of Motor Impairment in Huntington's Disease Huntington's Disease

Last updated: January 22, 2019
Sponsor: BioSensics
Overall Status: Active - Recruiting

Phase

N/A

Condition

Dyskinesias

Treatment

N/A

Clinical Study ID

NCT03599076
1R44NS103648-01
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The principal means of measuring motor impairment in Huntington disease (HD) is the Unified Huntington's Disease Rating Scale (UHDRS) total motor score, which is subjective, categorical, requires significant training to administer correctly, and only captures impairments in clinic. In this Direct to Phase II SBIR we will develop a wearable sensor system for objective, sensitive, and continuous assessment of Huntington's chorea during activities of daily living. The developed technology could be used clinically to detect changes in motor function in response to medications, or could be used scientifically to expedite and reduce the cost of early stage pharmaceutical clinical trials.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • CAG expansion ≥ 36

Exclusion

Exclusion Criteria:

Study Design

Total Participants: 50
Study Start date:
September 25, 2018
Estimated Completion Date:
December 31, 2019

Connect with a study center

  • University of Rochester

    Rochester, New York 14642
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.